4-pentyl-1H-1,2,3-triazole | 69228-52-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-pentyl-1H-1,2,3-triazole
• 英文别名: 4-Pentyl-1H-[1,2,3]triazol；4-pentyl-2H-triazole
• CAS: 69228-52-0
• 化学式: C₇H₁₃N₃
• 分子量: 139.2
• InChiKey: XMMXBKZYURWNPH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  41.6
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1-benzyl-4-pentyl-1H-1,2,3-triazole 在 1,1,2-三氯乙烷 、 palladium 10% on activated carbon 、 氢气 作用下， 以 甲醇 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 反应 24.0h， 以98%的产率得到4-pentyl-1H-1,2,3-triazole
  参考文献：
  名称：

  Debenzylation of Functionalized 4- and 5-Substituted 1,2,3-Triazoles

  摘要：

  A range of 4- and 5-substituted N-benzyl-1,2,3-triazoles have been submitted to debenzylation using Pd/C and hydrogen in the presence of 1,1,2-trichloroethane. Triazoles with oxygen-containing substituents are efficiently debenzylated under these conditions. Triazoles with a phenyl or benzyl substituent on C4 or C5 are not debenzylated, whereas a pentyl-substituted derivative was readily debenzylated.

  DOI：

  10.1055/s-0031-1291160

文献信息

• [EN] BRIDGED BENZIMIDAZOLE-CARBENE COMPLEXES AND USE THEREOF IN OLEDS<br/>[FR] COMPLEXES BENZIMIDAZOLE-CARBÈNE PONTÉS ET LEUR UTILISATION DANS LES DELO
  申请人：BASF SE

  公开号：WO2012020327A1

  公开（公告）日：2012-02-16

  The present invention concerns a metal-carbene complex of the general formula (I) in which R5 and R6 together, or R6 and R7 together, a unit of the formula: in which * denotes the connection to the carbon atoms of the benzene ring bearing the R5 and R6 radicals or R6 and R7 radicals, and the oxygen atom is connected to the carbon atom bearing the R5, R6 or R7 radical, and A is oxygen or sulfur. The present invention further concerns light-emitting layer comprising at least one metal-carbene complex according to the present invention and an organic light-emitting diode comprising a light-emitting layer according to the present invention, a device selected from the group consisting of stationary visual display units, mobile visual display units and illumination means and the use of a metal-carbene complex according to the present invention in organic light-emitting diodes, especially as emitter, matrix material, charge carrier material and charge blocker material.

  本发明涉及一种一般式（I）的金属-卡宾配合物，其中R5和R6一起，或R6和R7一起，形成一种具有以下结构的单元：其中*表示连接到苯环上携带R5和R6基团或R6和R7基团的碳原子，氧原子连接到携带R5、R6或R7基团的碳原子，A为氧或硫。本发明还涉及包括至少一种根据本发明的金属-卡宾配合物的发光层，以及包括根据本发明的发光层的有机发光二极管，所述设备选自固定式视觉显示单元、移动式视觉显示单元和照明装置，并且根据本发明的金属-卡宾配合物在有机发光二极管中的使用，特别是作为发射体、基质材料、载流子材料和阻挡材料。
• SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINOL DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE10A)
  申请人：Leblond Bertrand

  公开号：US20120214837A1

  公开（公告）日：2012-08-23

  The invention relates to compounds of the formula wherein R′, R 1 , through R 7 and Ar are as defined herein. These compounds are useful as inhibitors of phosphodiesterase 10 (PDE10A) which are useful in treating central nervous system diseases such as psychosis and also in treating, for example, obesity, type II diabetes, metabolic syndrome, glucose intolerance, pain and ophthalmic diseases.

  本发明涉及具有以下公式的化合物 其中R'，R1，到R7和Ar如本文所述定义。这些化合物作为磷酸二酯酶10（PDE10A）的抑制剂，可用于治疗中枢神经系统疾病，如精神疾病，也可用于治疗例如肥胖、2型糖尿病、代谢综合征、葡萄糖不耐受、疼痛和眼科疾病。
• [EN] COMPOUNDS AND METHODS FOR MODULATING FXR<br/>[FR] COMPOSÉS ET PROCÉDÉS POUR MODULER LE FXR
  申请人：LILLY CO ELI

  公开号：WO2009012125A1

  公开（公告）日：2009-01-22

  Compounds of formula (I): formula (I) wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and diseases related to dyslipidemia.

  公式(I)的化合物：其中变量如本文所述定义，其药物组合物及其用途被披露为用于治疗血脂异常以及与血脂异常相关的疾病。
• [EN] AMINOTRIAZOLE IMMUNOMODULATORS FOR TREATING AUTOIMMUNE DISEASES<br/>[FR] IMMUNOMODULATEURS D'AMINOTRIAZOLE POUR TRAITER DES MALADIES AUTO-IMMUNES
  申请人：UNIV ROCKEFELLER

  公开号：WO2017123518A1

  公开（公告）日：2017-07-20

  1-Acyl-3-(heteroaryl)-1H-1,2,4-triazol-5-amines of formula (I) are disclosed. These compounds inhibit Coagulation Factor XIIa in the presence of thrombin and other coagulation factors. They are useful to treat autoimmune diseases.

  1-酰基-3-(杂芳基)-1H-1,2,4-三唑-5-胺的公式(I)化合物被公开。这些化合物在存在凝血酶和其他凝血因子时抑制凝血因子XIIa。它们可用于治疗自身免疫疾病。
• [EN] SUBSTITUTED 6,7-DIALKOXY-3-ISOQUINOLINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE10A)<br/>[FR] DÉRIVÉS DE 6,7-DIALCOXY-3-ISOQUINOLINE SUBSTITUÉS À TITRE D'INHIBITEURS DE PHOSPHODIESTÉRASE 10 (PDE10A)
  申请人：ALLERGAN INC

  公开号：WO2014071044A1

  公开（公告）日：2014-05-08

  The invention relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein R', R1 through R7 and Ar are as defined herein. These compounds are useful as inhibitors of phosphodiesterase 10 (PDE10A) which are useful in treating central nervous system diseases such as psychosis and also in treating, for example, obesity, type II diabetes, metabolic syndrome, glucose intolerance, pain and ophthalmic diseases.

  本发明涉及公式（I）的化合物或其药用可接受盐，其中R'，R1至R7和Ar如本文所述定义。这些化合物作为磷酸二酯酶10（PDE10A）的抑制剂，可用于治疗中枢神经系统疾病，如精神疾病，也可用于治疗例如肥胖、II型糖尿病、代谢综合征、葡萄糖不耐症、疼痛和眼科疾病。